US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALPS Medical Breakthroughs ETF

70.33

+1.692.46%

Post-market: 70.330.00000.00%19:30 EDT

Volume:86.82K

Turnover:6.09M

Market Cap:240.88M

PE:- -

High:70.59

Open:69.39

Low:69.39

Close:68.64

52wk High:70.85

52wk Low:34.50

Shares:3.43M

Float Shares:3.43M

Volume Ratio:1.77

T/O Rate:2.53%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Sabio Boosts Margins and Programmatic Growth Ahead of Election-Driven Second Half

Should Xenon’s Wider Q2 Losses to Fund Neurology Pipeline Require Action From Xenon (XENE) Investors?

Simply Wall St.

Sabio Secures US$1.5 Million High-Interest Term Loan to Support Working Capital

AbbVie Closes USD 10B Multi-Tranche Senior Notes Offering to Fund Apogee Deal

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/SBIO"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","market":"US","secType":"STK","nameCN":"ALPS Medical Breakthroughs ETF","latestPrice":70.33,"timestamp":1787688000000,"preClose":68.64,"halted":0,"volume":86817,"hourTrading":{"tag":"盘后","latestPrice":70.33,"preClose":70.33,"latestTime":"19:30 EDT","volume":91,"amount":6415.95,"timestamp":1787700600971,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02462121212121209,"floatShares":3425000,"shares":3425000,"eps":0,"marketStatus":"Closed","change":1.69,"latestTime":"08-25 16:00:00 EDT","open":69.39,"high":70.59,"low":69.39,"amount":6093466.45116,"amplitude":0.017483,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":68.64,"sharesOutstanding":2675000,"nav":68.56,"aum":236522874.13,"bidAskSpread":0.002211,"preHourTrading":{"tag":"盘前","latestPrice":69.5,"preClose":68.64,"latestTime":"09:29 EDT","volume":3,"amount":208.5,"timestamp":1787664559664,"change":0.86,"changeRate":0.012529,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":70.33,"preClose":70.33,"latestTime":"19:30 EDT","volume":91,"amount":6415.95,"timestamp":1787700600971,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.770323,"impliedVol":0.2962,"impliedVolPercentile":0.9442},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","floatShares":3425000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.770323,"shares":3425000,"dividePrice":0,"high":70.59,"amplitude":0.017483,"preClose":68.64,"low":69.39,"week52Low":34.4999,"pbRate":"--","week52High":70.85,"institutionHeld":0,"latestPrice":70.33,"eps":0,"divideRate":0,"volume":86817,"delay":0,"ttmEps":0,"open":69.39,"prevYearClose":51.22,"prevWeekClose":69.11,"prevMonthClose":63.362,"prevQuarterClose":64.65,"fiveDayClose":69.09,"twentyDayClose":63.52,"sixtyDayClose":54.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SBIO\",params:#limit:5,,,undefined,":[{"date":"2024-12-19","symbol":"SBIO","amount":1.17346,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-19","defaultRemindTime":1734618600000,"name":"ALPS Medical Breakthroughs ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-19","currency":"USD","dateTimestamp":1734584400000,"payDate":"2024-12-26"},{"date":"2023-12-21","symbol":"SBIO","amount":0.07106,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-22","defaultRemindTime":1703169000000,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2023-12-27","payableDate":"2023-12-22","currency":"USD","dateTimestamp":1703134800000,"payDate":"2023-12-27"},{"market":"US","date":"2019-12-19","symbol":"SBIO","amount":0.01585,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2019-12-27","payableDate":"2019-12-20","currency":"USD","type":"dividend","dateTimestamp":1576731600000},{"market":"US","date":"2018-12-20","symbol":"SBIO","amount":0.78406,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2018-12-27","payableDate":"2018-12-21","currency":"USD","type":"dividend","dateTimestamp":1545282000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SBIO\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.78406,"currency":"USD"},{"executeDate":"2019-12-19","recordDate":"2019-12-20","paymentDate":"2019-12-27","value":0.01585,"currency":"USD"},{"executeDate":"2023-12-21","recordDate":"2023-12-22","paymentDate":"2023-12-27","value":0.07106,"currency":"USD"},{"executeDate":"2024-12-19","recordDate":"2024-12-19","paymentDate":"2024-12-26","value":1.17346,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SBIO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SBIO\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660476707","title":"Sabio Boosts Margins and Programmatic Growth Ahead of Election-Driven Second Half","url":"https://stock-news.laohu8.com/highlight/detail?id=2660476707","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660476707?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:32","pubTimestamp":1787178771,"startTime":"0","endTime":"0","summary":"Sabio Holdings ( ($TSE:SBIO) ) has issued an update. Sabio reported consolidated gross revenues of $9.7 million in the second quarter of 2026, with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sabio-boosts-margins-and-programmatic-growth-ahead-of-election-driven-second-half?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sabio-boosts-margins-and-programmatic-growth-ahead-of-election-driven-second-half?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660520417","title":"Should Xenon’s Wider Q2 Losses to Fund Neurology Pipeline Require Action From Xenon (XENE) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660520417","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660520417?lang=en_us&edition=fundamental","pubTime":"2026-08-19 12:51","pubTimestamp":1787115071,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals Inc. recently reported second-quarter 2026 results, with net loss rising to US$110.74 million and basic loss per share from continuing operations at US$1.11, alongside a six‑month net loss of US$213.04 million and basic loss per share of US$2.28.\nThe widening losses compared with the same periods in 2025 give investors fresh insight into how Xenon is funding its ion-channel neurology pipeline ahead of key clinical and commercial milestones.\nWe will now examine how...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-xene/xenon-pharmaceuticals/news/should-xenons-wider-q2-losses-to-fund-neurology-pipeline-req","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-xene/xenon-pharmaceuticals/news/should-xenons-wider-q2-losses-to-fund-neurology-pipeline-req","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","XENE","BK4139","SBIO","IBRN","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660411328","title":"Sabio Secures US$1.5 Million High-Interest Term Loan to Support Working Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2660411328","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660411328?lang=en_us&edition=fundamental","pubTime":"2026-08-19 11:02","pubTimestamp":1787108540,"startTime":"0","endTime":"0","summary":"Sabio Holdings ( ($TSE:SBIO) ) has shared an announcement. Sabio Holdings has secured a US$1.5 million non-revolving term loan facility through its...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sabio-secures-us1-5-million-high-interest-term-loan-to-support-working-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sabio-secures-us1-5-million-high-interest-term-loan-to-support-working-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492377","title":"AbbVie Closes USD 10B Multi-Tranche Senior Notes Offering to Fund Apogee Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492377","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492377?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:31","pubTimestamp":1787085094,"startTime":"0","endTime":"0","summary":"AbbVie closes USD 10B multi-tranche senior notes offering to fund Apogee dealAbbVie completed a USD 10 billion senior notes offering, including senior floating rate notes due 2028.Deal included fixed-rate senior notes across eight maturities from 2028 to 2066, with coupons from 4.5% to 6.1%.Proceeds earmarked to fund part of the cash consideration for AbbVie’s planned acquisition of Apogee Therapeutics.If the Apogee deal is terminated, AbbVie must redeem the floating-rate notes and fixed-rate notes due 2028-2038 at 101%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AbbVie Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLbzVC04:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1718418525.SGD","LU0256863811.USD","FTXH","GLAM","IE00BSNM7G36.USD","LU0708994859.HKD","IE00B19Z3581.USD","JDOC","LU0128525929.USD","LU0395794307.EUR","LU2237443622.USD","LU0114720955.EUR","LU0472753341.HKD","LU0417517546.SGD","SG9999001440.SGD","FHLC","LU0965508806.USD","LU0965509283.SGD","LU1989771016.USD","SBIO","IYH","IE000BZT7R73.USD","AGNG","VHT","LU2237443549.SGD","IE000SO60NU8.SGD","LU0203347892.USD","LU0310799852.SGD","PPH","LU1093756325.SGD","LU2125909593.SGD","BK4534","PJP","APGE","LU1839511570.USD","RXL","ABBV","LU0211328371.USD","LU0553294199.USD","LU2129689605.HKD","MEDX","IE00B4R5TH58.HKD","IXJ","TRUH","LU2433249047.HKD","LU0795875086.SGD","XLV","BK4533","LU0545039389.USD","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":18,"pageCount":1,"totalSize":70,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SBIO\",params:#limit:6,delay:false,,,undefined,":[]}}